SCHEMBL7653302

SCHEMBL7653302

COc1cc([N+](=O)[O-])c(N)cc1-c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 5/20 0.50
ALDH1A1 P00352 3/20 0.50
HTT P42858 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
HSP90AA1 P07900 1/20 0.45
CDK5 Q00535 1/20 0.45
CDK5R1 Q15078 1/20 0.45
ABCB1 P08183 7/20 0.44
CYP3A4 P08684 1/20 0.44
TSHR P16473 1/20 0.44
ABCC1 P33527 4/20 0.44
MEN1 O00255 1/20 0.44
POLB P06746 1/20 0.44
MAPT P10636 1/20 0.44
KMT2A Q03164 1/20 0.44
PTGDR2 Q9Y5Y4 1/20 0.43
PGR P06401 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10713235 0.82 TDP1 (0.58) TDP1ALDH1A1L3MBTL1HSP90AA1CDK5
SCHEMBL7657590 0.82 TDP1 (0.58) TDP1ALDH1A1L3MBTL1HSP90AA1CDK5
SCHEMBL6574674 0.82 TDP1 (0.50) TDP1ALDH1A1HTTL3MBTL1ABCB1
SCHEMBL17670218 0.82 TDP1 (0.50) TDP1ALDH1A1HTTL3MBTL1ABCB1
SCHEMBL4591818 0.81 ALDH1A1 (0.56) TDP1ALDH1A1L3MBTL1ABCB1CYP3A4
SCHEMBL4588501 0.81 TDP1 (0.54) TDP1ALDH1A1HTTL3MBTL1HSP90AA1
SCHEMBL25932256 0.80 TDP1 (0.51) TDP1ALDH1A1HSP90AA1CDK5CDK5R1
SCHEMBL6811812 0.80 LMNA (0.52) TDP1ALDH1A1ABCB1CYP3A4TSHR
SCHEMBL3480822 0.79 ALDH1A1 (0.58) TDP1ALDH1A1HTTL3MBTL1CYP3A4
SCHEMBL7649916 0.79 PGR (0.49) TDP1ALDH1A1CYP3A4TSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399642-B2 TRIS BENZIMIDAZOLES; FUNGICIDES, ANTICARCINOGENIC AGENTS, ENZYME INHIBITOR RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2002-06-04 US disclosed
US-20010009919-A1 Heterocyclic topoisomerase poisons RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2001-07-26 US disclosed
US-6221892-B1 Heterocyclic topoisomerase poisons THE STATE OF UNIVERSITY OF NEW JERSEY, RUTGERS 2001-04-24 US disclosed
EP-1054870-A1 HETEROCYCLIC TOPOISOMERASE POISONS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2000-11-29 EP disclosed
US-6063801-A Heterocyclic topoisomerase poisons RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2000-05-16 US disclosed
WO-1999041241-A1 HETEROCYCLIC TOPOISOMERASE POISONS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 1999-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010009919-A1 Heterocyclic topoisomerase poisons TOP1, TOP2A, TOP2B TDP1 4/4885ALDH1A1 2485/4885HTT 1871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.